1. Home
  2. RCUS vs NGVC Comparison

RCUS vs NGVC Comparison

Compare RCUS & NGVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • NGVC
  • Stock Information
  • Founded
  • RCUS 2015
  • NGVC 1955
  • Country
  • RCUS United States
  • NGVC United States
  • Employees
  • RCUS N/A
  • NGVC 4145
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • NGVC Food Chains
  • Sector
  • RCUS Health Care
  • NGVC Consumer Staples
  • Exchange
  • RCUS Nasdaq
  • NGVC Nasdaq
  • Market Cap
  • RCUS 906.4M
  • NGVC 863.6M
  • IPO Year
  • RCUS 2018
  • NGVC 2012
  • Fundamental
  • Price
  • RCUS $9.32
  • NGVC $37.67
  • Analyst Decision
  • RCUS Buy
  • NGVC
  • Analyst Count
  • RCUS 8
  • NGVC 0
  • Target Price
  • RCUS $20.86
  • NGVC N/A
  • AVG Volume (30 Days)
  • RCUS 721.6K
  • NGVC 198.4K
  • Earning Date
  • RCUS 08-07-2025
  • NGVC 08-07-2025
  • Dividend Yield
  • RCUS N/A
  • NGVC 1.30%
  • EPS Growth
  • RCUS N/A
  • NGVC 42.37
  • EPS
  • RCUS N/A
  • NGVC 1.78
  • Revenue
  • RCUS $141,000,000.00
  • NGVC $1,297,733,000.00
  • Revenue This Year
  • RCUS N/A
  • NGVC $1.32
  • Revenue Next Year
  • RCUS $28.73
  • NGVC N/A
  • P/E Ratio
  • RCUS N/A
  • NGVC $21.14
  • Revenue Growth
  • RCUS N/A
  • NGVC 9.36
  • 52 Week Low
  • RCUS $6.50
  • NGVC $22.14
  • 52 Week High
  • RCUS $18.98
  • NGVC $61.22
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 55.03
  • NGVC 34.60
  • Support Level
  • RCUS $9.14
  • NGVC $39.52
  • Resistance Level
  • RCUS $10.34
  • NGVC $40.95
  • Average True Range (ATR)
  • RCUS 0.48
  • NGVC 1.25
  • MACD
  • RCUS 0.07
  • NGVC 0.03
  • Stochastic Oscillator
  • RCUS 48.91
  • NGVC 1.34

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About NGVC Natural Grocers by Vitamin Cottage Inc.

Natural Grocers by Vitamin Cottage Inc operates natural and organic grocery and dietary supplement stores. It offers the following product categories, natural and organic food, dietary supplements, natural body care, household, pet care products, books and handouts. The Company has a single reporting segment, natural and organic retail stores, through which business are conducted. The company generates the majority of its revenue from grocery products and dietary supplements and rest from other products.

Share on Social Networks: